LineLabelWBD-PValueSourceMessage
1Primary Concepts [http://www.SampleCompany.com/PrimaryConcepts]
2Context D-2003-Agri[from 2003-01-01 to 2003-12-31 for SAMP]
3U-Euros
4primary:Revenue for Primary Segment, Total CD 06,693,000,000bothOK
5primary:Sales to External Customers for Segment1CD 06,693,000,000inst 
 
6Context D-2003-AH[from 2003-01-01 to 2003-12-31 for SAMP]
7U-Euros
8primary:Revenue for Primary Segment, Total CD 01,083,000,000bothOK
9primary:Sales to External Customers for Segment1CD 01,083,000,000inst 
10primary:Sales from Transactions with Other Segments for Segment1CD 00inst 
 
11Context D-2003-CH[from 2003-01-01 to 2003-12-31 for SAMP]
12U-Euros
13primary:Revenue for Primary Segment, Total CD 06,556,000,000bothOK
14primary:Sales to External Customers for Segment1CD 06,514,000,000inst 
15primary:Sales from Transactions with Other Segments for Segment1CD 042,000,000inst 
 
16Context D-2003-CIBA[from 2003-01-01 to 2003-12-31 for SAMP]
17U-Euros
18primary:Revenue for Primary Segment, Total CD 01,400,000,000bothOK
19primary:Sales to External Customers for Segment1CD 01,392,000,000inst 
20primary:Sales from Transactions with Other Segments for Segment1CD 08,000,000inst 
 
21Context D-2003-Continuing[from 2003-01-01 to 2003-12-31 for SAMP]
22U-Euros
23primary:Revenue for Primary Segment, Total CD 029,112,000,000bothOK
24primary:Sales to External Customers for Segment1CD 029,112,000,000inst 
 
25Context D-2003-Corp[from 2003-01-01 to 2003-12-31 for SAMP]
26U-Euros
27primary:Revenue for Primary Segment, Total CD 0(465,000,000)bothOK
28primary:Sales from Transactions with Other Segments for Segment1CD 0(465,000,000)inst 
 
29Context D-2003-Discontinued[from 2003-01-01 to 2003-12-31 for SAMP]
30U-Euros
31primary:Revenue for Primary Segment, Total CD 06,693,000,000bothOK
32primary:Sales to External Customers for Segment1CD 06,693,000,000inst 
 
33Context D-2003-Gen[from 2003-01-01 to 2003-12-31 for SAMP]
34U-Euros
35primary:Revenue for Primary Segment, Total CD 02,143,000,000bothOK
36primary:Sales to External Customers for Segment1CD 01,973,000,000inst 
37primary:Sales from Transactions with Other Segments for Segment1CD 0170,000,000inst 
 
38Context D-2003-Pharm[from 2003-01-01 to 2003-12-31 for SAMP]
39U-Euros
40primary:Revenue for Primary Segment, Total CD 018,395,000,000bothOK
41primary:Sales to External Customers for Segment1CD 018,150,000,000inst 
42primary:Sales from Transactions with Other Segments for Segment1CD 0245,000,000inst 
 
43Context D-2003-Total[from 2003-01-01 to 2003-12-31 for SAMP]
44U-Euros
45primary:Revenue for Primary Segment, Total CD 035,805,000,000bothOK
46primary:Sales to External Customers for Segment1CD 035,805,000,000inst 
 
47Context D-2004-Agri[from 2004-01-01 to 2004-12-31 for SAMP]
48U-Euros
49primary:Revenue for Primary Segment, Total CD 00bothOK
50primary:Sales to External Customers for Segment1CD 00inst 
 
51Context D-2004-AH[from 2004-01-01 to 2004-12-31 for SAMP]
52U-Euros
53primary:Revenue for Primary Segment, Total CD 0977,000,000bothOK
54primary:Sales to External Customers for Segment1CD 0962,000,000inst 
55primary:Sales from Transactions with Other Segments for Segment1CD 015,000,000inst 
 
56Context D-2004-CH[from 2004-01-01 to 2004-12-31 for SAMP]
57U-Euros
58primary:Revenue for Primary Segment, Total CD 06,704,000,000bothOK
59primary:Sales to External Customers for Segment1CD 06,675,000,000inst 
60primary:Sales from Transactions with Other Segments for Segment1CD 029,000,000inst 
 
61Context D-2004-CIBA[from 2004-01-01 to 2004-12-31 for SAMP]
62U-Euros
63primary:Revenue for Primary Segment, Total CD 01,804,000,000bothOK
64primary:Sales to External Customers for Segment1CD 01,787,000,000inst 
65primary:Sales from Transactions with Other Segments for Segment1CD 017,000,000inst 
 
66Context D-2004-Continuing[from 2004-01-01 to 2004-12-31 for SAMP]
67U-Euros
68primary:Revenue for Primary Segment, Total CD 032,038,000,000bothOK
69primary:Sales to External Customers for Segment1CD 032,038,000,000inst 
 
70Context D-2004-Corp[from 2004-01-01 to 2004-12-31 for SAMP]
71U-Euros
72primary:Revenue for Primary Segment, Total CD 0(494,000,000)bothOK
73primary:Sales from Transactions with Other Segments for Segment1CD 0(494,000,000)inst 
 
74Context D-2004-Discontinued[from 2004-01-01 to 2004-12-31 for SAMP]
75U-Euros
76primary:Revenue for Primary Segment, Total CD 00bothOK
77primary:Sales to External Customers for Segment1CD 00inst 
 
78Context D-2004-Gen[from 2004-01-01 to 2004-12-31 for SAMP]
79U-Euros
80primary:Revenue for Primary Segment, Total CD 02,636,000,000bothOK
81primary:Sales to External Customers for Segment1CD 02,433,000,000inst 
82primary:Sales from Transactions with Other Segments for Segment1CD 0203,000,000inst 
 
83Context D-2004-Pharm[from 2004-01-01 to 2004-12-31 for SAMP]
84U-Euros
85primary:Revenue for Primary Segment, Total CD 020,411,000,000bothOK
86primary:Sales to External Customers for Segment1CD 020,181,000,000inst 
87primary:Sales from Transactions with Other Segments for Segment1CD 0230,000,000inst 
 
88Context D-2004-Total[from 2004-01-01 to 2004-12-31 for SAMP]
89U-Euros
90primary:Revenue for Primary Segment, Total CD 032,038,000,000bothOK
91primary:Sales to External Customers for Segment1CD 032,038,000,000inst 
 
92Context I-2003-Agri[at 2003-12-31 for SAMP]
93U-Euros
94primary:Equity and Liabilities, Total CD 00bothOK
95primary:Liabilities, Total1CD 00inst 
96primary:Equity, Total1CD 00inst 
 
97Context I-2003-AH[at 2003-12-31 for SAMP]
98U-Euros
99primary:Equity and Liabilities, Total CD 0842,000,000bothOK
100primary:Liabilities, Total1CD 0198,000,000inst 
101primary:Equity, Total1CD 0644,000,000inst 
 
102Context I-2003-CH[at 2003-12-31 for SAMP]
103U-Euros
104primary:Equity and Liabilities, Total CD 04,426,000,000bothOK
105primary:Liabilities, Total1CD 02,142,000,000inst 
106primary:Equity, Total1CD 02,284,000,000inst 
 
107Context I-2003-CIBA[at 2003-12-31 for SAMP]
108U-Euros
109primary:Equity and Liabilities, Total CD 03,169,000,000bothOK
110primary:Liabilities, Total1CD 0824,000,000inst 
111primary:Equity, Total1CD 02,345,000,000inst 
 
112Context I-2003-Continuing[at 2003-12-31 for SAMP]
113U-Euros
114primary:Equity and Liabilities, Total CD 058,196,000,000bothOK
115primary:Liabilities, Total1CD 021,256,000,000inst 
116primary:Equity, Total1CD 036,940,000,000inst 
 
117Context I-2003-Corp[at 2003-12-31 for SAMP]
118U-Euros
119primary:Equity and Liabilities, Total CD 030,297,000,000bothOK
120primary:Liabilities, Total1CD 012,979,000,000inst 
121primary:Equity, Total1CD 017,318,000,000inst 
 
122Context I-2003-Discontinued[at 2003-12-31 for SAMP]
123U-Euros
124primary:Equity and Liabilities, Total CD 00bothOK
125primary:Liabilities, Total1CD 00inst 
126primary:Equity, Total1CD 00inst 
 
127Context I-2003-Gen[at 2003-12-31 for SAMP]
128U-Euros
129primary:Equity and Liabilities, Total CD 02,575,000,000bothOK
130primary:Liabilities, Total1CD 0636,000,000inst 
131primary:Equity, Total1CD 01,939,000,000inst 
 
132Context I-2003-Pharm[at 2003-12-31 for SAMP]
133U-Euros
134primary:Equity and Liabilities, Total CD 016,887,000,000bothOK
135primary:Liabilities, Total1CD 04,477,000,000inst 
136primary:Equity, Total1CD 012,410,000,000inst 
 
137Context I-2003-Total[at 2003-12-31 for SAMP]
138U-Euros
139primary:Equity and Liabilities, Total CD 058,196,000,000bothOK
140primary:Liabilities, Total1CD 021,256,000,000inst 
141primary:Equity, Total1CD 036,940,000,000inst 
 
142Context I-2004-Agri[at 2004-12-31 for SAMP]
143U-Euros
144primary:Equity and Liabilities, Total CD 00bothOK
145primary:Liabilities, Total1CD 00inst 
146primary:Equity, Total1CD 00inst 
 
147Context I-2004-AH[at 2004-12-31 for SAMP]
148U-Euros
149primary:Equity and Liabilities, Total CD 0735,000,000bothOK
150primary:Liabilities, Total1CD 0163,000,000inst 
151primary:Equity, Total1CD 0572,000,000inst 
 
152Context I-2004-CH[at 2004-12-31 for SAMP]
153U-Euros
154primary:Equity and Liabilities, Total CD 04,686,000,000bothOK
155primary:Liabilities, Total1CD 02,158,000,000inst 
156primary:Equity, Total1CD 02,528,000,000inst 
 
157Context I-2004-CIBA[at 2004-12-31 for SAMP]
158U-Euros
159primary:Equity and Liabilities, Total CD 02,909,000,000bothOK
160primary:Liabilities, Total1CD 0599,000,000inst 
161primary:Equity, Total1CD 02,310,000,000inst 
 
162Context I-2004-Continuing[at 2004-12-31 for SAMP]
163U-Euros
164primary:Equity and Liabilities, Total CD 066,785,000,000bothOK
165primary:Liabilities, Total1CD 024,436,000,000inst 
166primary:Equity, Total1CD 042,349,000,000inst 
 
167Context I-2004-Corp[at 2004-12-31 for SAMP]
168U-Euros
169primary:Equity and Liabilities, Total CD 036,462,000,000bothOK
170primary:Liabilities, Total1CD 015,289,000,000inst 
171primary:Equity, Total1CD 021,173,000,000inst 
 
172Context I-2004-Discontinued[at 2004-12-31 for SAMP]
173U-Euros
174primary:Equity and Liabilities, Total CD 00bothOK
175primary:Liabilities, Total1CD 00inst 
176primary:Equity, Total1CD 00inst 
 
177Context I-2004-Gen[at 2004-12-31 for SAMP]
178U-Euros
179primary:Equity and Liabilities, Total CD 03,362,000,000bothOK
180primary:Liabilities, Total1CD 0740,000,000inst 
181primary:Equity, Total1CD 02,622,000,000inst 
 
182Context I-2004-Pharm[at 2004-12-31 for SAMP]
183U-Euros
184primary:Equity and Liabilities, Total CD 018,631,000,000bothOK
185primary:Liabilities, Total1CD 05,487,000,000inst 
186primary:Equity, Total1CD 013,144,000,000inst 
 
187Context I-2004-Total[at 2004-12-31 for SAMP]
188U-Euros
189primary:Equity and Liabilities, Total CD 066,785,000,000bothOK
190primary:Liabilities, Total1CD 024,436,000,000inst 
191primary:Equity, Total1CD 042,349,000,000inst 
 
192Dimensions period from 2003-01-01 to 2003-12-31 for SAMP
193U-Euros
194company:Operations (Placeholder)//operations:Continuing
195primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group]  D 01,179,000,000bothOK
196primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1 D 0534,000,000inst 
197primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1 D 0241,000,000inst 
198primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1 D 0122,000,000inst 
199primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1 D 0120,000,000inst 
200primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1 D 020,000,000inst 
201primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1 D 0142,000,000inst 
202primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Group] DD 04,011,000,000bothOK
203primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 03,311,000,000inst 
204primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0170,000,000inst 
205primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0186,000,000inst 
206primary:Research and Development[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 067,000,000inst 
207primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 088,000,000inst 
208primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 0189,000,000inst 
209primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Group] DD 0(101,000,000)bothOK
210primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 0(42,000,000)inst 
211primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0(16,000,000)inst 
212primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0(2,000,000)inst 
213primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 0(41,000,000)inst 
214primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
215primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 00inst 
216primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 06,727,000,000bothOK
217primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 05,401,000,000inst 
218primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 0242,000,000inst 
219primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 0869,000,000inst 
220primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 0100,000,000inst 
221primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0179,000,000inst 
222primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 0(64,000,000)inst 
223primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 029,112,000,000bothOK
224primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 018,395,000,000inst 
225primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,143,000,000inst 
226primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 06,556,000,000inst 
227primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 01,400,000,000inst 
228primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 01,083,000,000inst 
229primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 0(465,000,000)inst 
230primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Group] DD 0205,000,000bothOK
231primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 062,000,000inst 
232primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Generics]1DD 058,000,000inst 
233primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 038,000,000inst 
234primary:Amortisation[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 032,000,000inst 
235primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 012,000,000inst 
236primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 03,000,000inst 
237primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 097,000,000bothOK
238primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 0104,000,000inst 
239primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 01,000,000inst 
240primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 0(7,000,000)inst 
241primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 0(1,000,000)inst 
242primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 00inst 
243primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 00inst 
244primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Group] DD 0968,000,000bothOK
245primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 0622,000,000inst 
246primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0115,000,000inst 
247primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0101,000,000inst 
248primary:Depreciation[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 086,000,000inst 
249primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 012,000,000inst 
250primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 032,000,000inst 
251primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] DD 02,000,000bothOK
252primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 02,000,000inst 
253primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1DD 00inst 
254primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 00inst 
255primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 00inst 
256primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
257primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 00inst 
258primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 029,112,000,000bothOK
259primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 018,150,000,000inst 
260primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 01,973,000,000inst 
261primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 06,514,000,000inst 
262primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 01,392,000,000inst 
263primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 01,083,000,000inst 
 
264company:Operations (Placeholder)//operations:Discontinued
265primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group]  D 0174,000,000bothOK
266primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1 D 0174,000,000inst 
267primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Group] DD 0646,000,000bothOK
268primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 0646,000,000inst 
269primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
270primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
271primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 01,156,000,000bothOK
272primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 01,156,000,000inst 
273primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 06,693,000,000bothOK
274primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 06,693,000,000inst 
275primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Group] DD 0104,000,000bothOK
276primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 0104,000,000inst 
277primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 01,000,000bothOK
278primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 01,000,000inst 
279primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Group] DD 0221,000,000bothOK
280primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 0221,000,000inst 
281primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] DD 05,000,000bothOK
282primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 05,000,000inst 
283primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 06,693,000,000bothOK
284primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 06,693,000,000inst 
 
285company:Sectors (Placeholder)//sectors:Group
286primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Total]  D 01,353,000,000bothOK
287primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1 D 01,179,000,000inst 
288primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1 D 0174,000,000inst 
289primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Total] CD 07,252,000,000bothOK
290primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Continuing]1CD 06,536,000,000inst 
291primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Discontinued]1CD 0716,000,000inst 
292primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Total] CD 07,210,000,000bothOK
293primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Continuing]1CD 06,511,000,000inst 
294primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Discontinued]1CD 0699,000,000inst 
295primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Total] CD 042,000,000bothOK
296primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Continuing]1CD 025,000,000inst 
297primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Discontinued]1CD 017,000,000inst 
298primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Total] CD 09,072,000,000bothOK
299primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Continuing]1CD 08,040,000,000inst 
300primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Discontinued]1CD 01,032,000,000inst 
301primary:Research and Development[..., company:Operations (Placeholder)//operations:Total] DD 04,657,000,000bothOK
302primary:Research and Development[..., company:Operations (Placeholder)//operations:Continuing]1DD 04,011,000,000inst 
303primary:Research and Development[..., company:Operations (Placeholder)//operations:Discontinued]1DD 0646,000,000inst 
304primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Total] DD 0(101,000,000)bothOK
305primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Continuing]1DD 0(101,000,000)inst 
306primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
307primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Total] CD 07,883,000,000bothOK
308primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 06,727,000,000inst 
309primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 01,156,000,000inst 
310primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Total] CD 035,805,000,000bothOK
311primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 029,112,000,000inst 
312primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 06,693,000,000inst 
313primary:Amortisation[..., company:Operations (Placeholder)//operations:Total] DD 0309,000,000bothOK
314primary:Amortisation[..., company:Operations (Placeholder)//operations:Continuing]1DD 0205,000,000inst 
315primary:Amortisation[..., company:Operations (Placeholder)//operations:Discontinued]1DD 0104,000,000inst 
316primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Total] CD 098,000,000bothOK
317primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 097,000,000inst 
318primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 01,000,000inst 
319primary:Depreciation[..., company:Operations (Placeholder)//operations:Total] DD 01,189,000,000bothOK
320primary:Depreciation[..., company:Operations (Placeholder)//operations:Continuing]1DD 0968,000,000inst 
321primary:Depreciation[..., company:Operations (Placeholder)//operations:Discontinued]1DD 0221,000,000inst 
322primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Total] DD 0(1,091,000,000)bothOK
323primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Continuing]1DD 0(1,216,000,000)inst 
324primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Discontinued]1DD 0125,000,000inst 
325primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Total] DD 07,000,000bothOK
326primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1DD 02,000,000inst 
327primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1DD 05,000,000inst 
328primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Total] DD 01,820,000,000bothOK
329primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Continuing]1DD 01,504,000,000inst 
330primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Discontinued]1DD 0316,000,000inst 
331primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Total] CD 035,805,000,000bothOK
332primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 029,112,000,000inst 
333primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 06,693,000,000inst 
 
334Dimensions period at 2003-12-31 for SAMP
335U-Euros
336company:Operations (Placeholder)//operations:Continuing
337primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Group] DD 09,030,000,000bothOK
338primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 05,770,000,000inst 
339primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0974,000,000inst 
340primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0880,000,000inst 
341primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 0648,000,000inst 
342primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 072,000,000inst 
343primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 0686,000,000inst 
344primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 058,196,000,000bothOK
345primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 016,887,000,000inst 
346primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Generics]1DD 02,575,000,000inst 
347primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 04,426,000,000inst 
348primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 03,169,000,000inst 
349primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 0842,000,000inst 
350primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 030,297,000,000inst 
351primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 058,196,000,000bothOK
352primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 016,887,000,000inst 
353primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,575,000,000inst 
354primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 04,426,000,000inst 
355primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 03,169,000,000inst 
356primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0842,000,000inst 
357primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 030,297,000,000inst 
358primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 01,531,000,000bothOK
359primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 01,375,000,000inst 
360primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Generics]1DD 05,000,000inst 
361primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 02,000,000inst 
362primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 05,000,000inst 
363primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
364primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 0144,000,000inst 
365primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 036,940,000,000bothOK
366primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 012,410,000,000inst 
367primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 01,939,000,000inst 
368primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 02,284,000,000inst 
369primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 02,345,000,000inst 
370primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0644,000,000inst 
371primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 017,318,000,000inst 
372primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 021,256,000,000bothOK
373primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 04,477,000,000inst 
374primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 0636,000,000inst 
375primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 02,142,000,000inst 
376primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 0824,000,000inst 
377primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0198,000,000inst 
378primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 012,979,000,000inst 
 
379company:Operations (Placeholder)//operations:Discontinued
380primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
381primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
382primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
383primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
384primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
385primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
386primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
387primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
388primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
389primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
390primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
391primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
 
392company:Sectors (Placeholder)//sectors:Group
393primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Total] DD 09,030,000,000bothOK
394primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Continuing]1DD 09,030,000,000inst 
395primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
396primary:Assets, Total[..., company:Operations (Placeholder)//operations:Total] DD 058,196,000,000bothOK
397primary:Assets, Total[..., company:Operations (Placeholder)//operations:Continuing]1DD 058,196,000,000inst 
398primary:Assets, Total[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
399primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Total] CD 058,196,000,000bothOK
400primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 058,196,000,000inst 
401primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
402primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Total] DD 01,531,000,000bothOK
403primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Continuing]1DD 01,531,000,000inst 
404primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
405primary:Equity, Total[..., company:Operations (Placeholder)//operations:Total] CD 036,940,000,000bothOK
406primary:Equity, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 036,940,000,000inst 
407primary:Equity, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
408primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Total] CD 021,256,000,000bothOK
409primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 021,256,000,000inst 
410primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
 
411U-Pure
412company:Operations (Placeholder)//operations:Continuing
413primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Group]  D 067,653bothOK
414primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1 D 038,397inst 
415primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Generics]1 D 05,712inst 
416primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Consumer Health]1 D 012,949inst 
417primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1 D 07,644inst 
418primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Animal Health]1 D 01,975inst 
419primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Corporate]1 D 0976inst 
 
420company:Operations (Placeholder)//operations:Discontinued
421primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Group]  D 00bothOK
422primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Agribusiness]1 D 00inst 
 
423company:Sectors (Placeholder)//sectors:Group
424primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Total]  D 067,653bothOK
425primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Continuing]1 D 067,653inst 
426primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Discontinued]1 D 00inst 
 
427Dimensions period from 2004-01-01 to 2004-12-31 for SAMP
428U-Euros
429company:Operations (Placeholder)//operations:Continuing
430primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group]  D 01,351,000,000bothOK
431primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1 D 0617,000,000inst 
432primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1 D 0209,000,000inst 
433primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1 D 0129,000,000inst 
434primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1 D 0153,000,000inst 
435primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1 D 019,000,000inst 
436primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1 D 0224,000,000inst 
437primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Group] DD 04,189,000,000bothOK
438primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 03,447,000,000inst 
439primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0169,000,000inst 
440primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0181,000,000inst 
441primary:Research and Development[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 098,000,000inst 
442primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 093,000,000inst 
443primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 0201,000,000inst 
444primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Group] DD 0(21,000,000)bothOK
445primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 00inst 
446primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Generics]1DD 00inst 
447primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0(21,000,000)inst 
448primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 00inst 
449primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
450primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 00inst 
451primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 07,277,000,000bothOK
452primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 05,677,000,000inst 
453primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 0281,000,000inst 
454primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 0920,000,000inst 
455primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 0174,000,000inst 
456primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0138,000,000inst 
457primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 087,000,000inst 
458primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 032,038,000,000bothOK
459primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 020,411,000,000inst 
460primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,636,000,000inst 
461primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 06,704,000,000inst 
462primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 01,804,000,000inst 
463primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0977,000,000inst 
464primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 0(494,000,000)inst 
465primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Group] DD 0564,000,000bothOK
466primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 0306,000,000inst 
467primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Generics]1DD 087,000,000inst 
468primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 045,000,000inst 
469primary:Amortisation[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 0102,000,000inst 
470primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 015,000,000inst 
471primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 09,000,000inst 
472primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 0139,000,000bothOK
473primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 0190,000,000inst 
474primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,000,000inst 
475primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 0(14,000,000)inst 
476primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 00inst 
477primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 00inst 
478primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 0(39,000,000)inst 
479primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Group] DD 0939,000,000bothOK
480primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 0578,000,000inst 
481primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Generics]1DD 0126,000,000inst 
482primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0105,000,000inst 
483primary:Depreciation[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 096,000,000inst 
484primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 014,000,000inst 
485primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 020,000,000inst 
486primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] DD 0246,000,000bothOK
487primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 0242,000,000inst 
488primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Generics]1DD 00inst 
489primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 04,000,000inst 
490primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 00inst 
491primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
492primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 00inst 
493primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 032,038,000,000bothOK
494primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 020,181,000,000inst 
495primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,433,000,000inst 
496primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 06,675,000,000inst 
497primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 01,787,000,000inst 
498primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0962,000,000inst 
 
499company:Operations (Placeholder)//operations:Discontinued
500primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group]  D 00bothOK
501primary:Accrual-Based Capital Additions for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1 D 00inst 
502primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
503primary:Research and Development[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
504primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
505primary:Restructuring Costs[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
506primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
507primary:Result for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
508primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
509primary:Revenue for Primary Segment, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
510primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
511primary:Amortisation[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
512primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
513primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
514primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
515primary:Depreciation[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
516primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
517primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
518primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
519primary:Sales to External Customers for Segment[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
 
520company:Sectors (Placeholder)//sectors:Group
521primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Total]  D 01,351,000,000bothOK
522primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1 D 01,351,000,000inst 
523primary:Accrual-Based Capital Additions for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1 D 00inst 
524primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Total] CD 07,043,000,000bothOK
525primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Continuing]1CD 07,043,000,000inst 
526primary:Profit (Loss)[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
527primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Total] CD 07,024,000,000bothOK
528primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Continuing]1CD 07,024,000,000inst 
529primary:Profit (Loss) Attributable to Equity Holders of Parent[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
530primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Total] CD 019,000,000bothOK
531primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Continuing]1CD 019,000,000inst 
532primary:Profit (Loss) Attributable to Minority Interest[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
533primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Total] CD 08,483,000,000bothOK
534primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Continuing]1CD 08,483,000,000inst 
535primary:Profit (Loss) Before Tax[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
536primary:Research and Development[..., company:Operations (Placeholder)//operations:Total] DD 04,189,000,000bothOK
537primary:Research and Development[..., company:Operations (Placeholder)//operations:Continuing]1DD 04,189,000,000inst 
538primary:Research and Development[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
539primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Total] DD 0(21,000,000)bothOK
540primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Continuing]1DD 0(21,000,000)inst 
541primary:Restructuring Costs[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
542primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Total] CD 07,277,000,000bothOK
543primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 07,277,000,000inst 
544primary:Result for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
545primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Total] CD 032,038,000,000bothOK
546primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 032,038,000,000inst 
547primary:Revenue for Primary Segment, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
548primary:Amortisation[..., company:Operations (Placeholder)//operations:Total] DD 0564,000,000bothOK
549primary:Amortisation[..., company:Operations (Placeholder)//operations:Continuing]1DD 0564,000,000inst 
550primary:Amortisation[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
551primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Total] CD 0139,000,000bothOK
552primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 0139,000,000inst 
553primary:Share of Profit (Loss) from Equity-Accounted Investments for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
554primary:Depreciation[..., company:Operations (Placeholder)//operations:Total] DD 0939,000,000bothOK
555primary:Depreciation[..., company:Operations (Placeholder)//operations:Continuing]1DD 0939,000,000inst 
556primary:Depreciation[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
557primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Total] DD 0(1,067,000,000)bothOK
558primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Continuing]1DD 0(1,067,000,000)inst 
559primary:Finance Costs [for Non-Financial Activities][..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
560primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Total] DD 0246,000,000bothOK
561primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Continuing]1DD 0246,000,000inst 
562primary:Impairment Loss Recognised Directly into Equity for Primary Segment[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
563primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Total] DD 01,440,000,000bothOK
564primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Continuing]1DD 01,440,000,000inst 
565primary:Income Tax Expense (Income)[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
566primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Total] CD 032,038,000,000bothOK
567primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Continuing]1CD 032,038,000,000inst 
568primary:Sales to External Customers for Segment[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
 
569Dimensions period at 2004-12-31 for SAMP
570U-Euros
571company:Operations (Placeholder)//operations:Continuing
572primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Group] DD 09,060,000,000bothOK
573primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 05,897,000,000inst 
574primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Generics]1DD 01,081,000,000inst 
575primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 0893,000,000inst 
576primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 0579,000,000inst 
577primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 073,000,000inst 
578primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 0537,000,000inst 
579primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 066,785,000,000bothOK
580primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 018,631,000,000inst 
581primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Generics]1DD 03,362,000,000inst 
582primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 04,686,000,000inst 
583primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 02,909,000,000inst 
584primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 0735,000,000inst 
585primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 036,462,000,000inst 
586primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 066,785,000,000bothOK
587primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 018,631,000,000inst 
588primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 03,362,000,000inst 
589primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 04,686,000,000inst 
590primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 02,909,000,000inst 
591primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0735,000,000inst 
592primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 036,462,000,000inst 
593primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 06,715,000,000bothOK
594primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1DD 01,554,000,000inst 
595primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Generics]1DD 07,000,000inst 
596primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1DD 00inst 
597primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1DD 00inst 
598primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1DD 00inst 
599primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1DD 05,154,000,000inst 
600primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 042,349,000,000bothOK
601primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 013,144,000,000inst 
602primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 02,622,000,000inst 
603primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 02,528,000,000inst 
604primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 02,310,000,000inst 
605primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0572,000,000inst 
606primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 021,173,000,000inst 
607primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 024,436,000,000bothOK
608primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1CD 05,487,000,000inst 
609primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Generics]1CD 0740,000,000inst 
610primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Consumer Health]1CD 02,158,000,000inst 
611primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1CD 0599,000,000inst 
612primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Animal Health]1CD 0163,000,000inst 
613primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Corporate]1CD 015,289,000,000inst 
 
614company:Operations (Placeholder)//operations:Discontinued
615primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
616primary:Property, Plant and Equipment, Net[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
617primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
618primary:Assets, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
619primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
620primary:Equity and Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
621primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Group] DD 00bothOK
622primary:Equity Method Accounted Investments, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1DD 00inst 
623primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
624primary:Equity, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
625primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Group] CD 00bothOK
626primary:Liabilities, Total[..., company:Sectors (Placeholder)//sectors:Agribusiness]1CD 00inst 
 
627company:Sectors (Placeholder)//sectors:Group
628primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Total] DD 09,060,000,000bothOK
629primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Continuing]1DD 09,060,000,000inst 
630primary:Property, Plant and Equipment, Net[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
631primary:Assets, Total[..., company:Operations (Placeholder)//operations:Total] DD 066,785,000,000bothOK
632primary:Assets, Total[..., company:Operations (Placeholder)//operations:Continuing]1DD 066,785,000,000inst 
633primary:Assets, Total[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
634primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Total] CD 066,785,000,000bothOK
635primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 066,785,000,000inst 
636primary:Equity and Liabilities, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
637primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Total] DD 06,715,000,000bothOK
638primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Continuing]1DD 06,715,000,000inst 
639primary:Equity Method Accounted Investments, Total[..., company:Operations (Placeholder)//operations:Discontinued]1DD 00inst 
640primary:Equity, Total[..., company:Operations (Placeholder)//operations:Total] CD 042,349,000,000bothOK
641primary:Equity, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 042,349,000,000inst 
642primary:Equity, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
643primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Total] CD 024,436,000,000bothOK
644primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Continuing]1CD 024,436,000,000inst 
645primary:Liabilities, Total[..., company:Operations (Placeholder)//operations:Discontinued]1CD 00inst 
 
646U-Pure
647company:Operations (Placeholder)//operations:Continuing
648primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Group]  D 071,116bothOK
649primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Pharmaceuticals]1 D 041,256inst 
650primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Generics]1 D 07,230inst 
651primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Consumer Health]1 D 012,824inst 
652primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:CIBA Vision]1 D 06,797inst 
653primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Animal Health]1 D 01,997inst 
654primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Corporate]1 D 01,012inst 
 
655company:Operations (Placeholder)//operations:Discontinued
656primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Group]  D 00bothOK
657primary:Number of Employees at End of Period[..., company:Sectors (Placeholder)//sectors:Agribusiness]1 D 00inst 
 
658company:Sectors (Placeholder)//sectors:Group
659primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Total]  D 071,116bothOK
660primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Continuing]1 D 071,116inst 
661primary:Number of Employees at End of Period[..., company:Operations (Placeholder)//operations:Discontinued]1 D 00inst 


Contexts
IDD-2004-Pharm
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Pharmaceuticals
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Pharm
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Pharmaceuticals
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Gen
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Generics
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Gen
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Generics
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-CH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Consumer Health
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-CH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Consumer Health
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-CIBA
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:CIBA Vision
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-CIBA
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:CIBA Vision
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-AH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Animal Health
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-AH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Animal Health
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Corp
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Corporate
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Corp
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Corporate
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Continuing
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Continuing
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Agri
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Agribusiness
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Agri
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Agribusiness
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Discontinued
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Discontinued
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2003-01-01 to 2003-12-31
 
IDD-2004-Total
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Total
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2004-01-01 to 2004-12-31
 
IDD-2003-Total
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Total
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodfrom 2003-01-01 to 2003-12-31
 
IDI-2004-Pharm
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Pharmaceuticals
Periodat 2004-12-31
 
IDI-2003-Pharm
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Pharmaceuticals
Periodat 2003-12-31
 
IDI-2004-Gen
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Generics
Periodat 2004-12-31
 
IDI-2003-Gen
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Generics
Periodat 2003-12-31
 
IDI-2004-CH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Consumer Health
Periodat 2004-12-31
 
IDI-2003-CH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Consumer Health
Periodat 2003-12-31
 
IDI-2004-CIBA
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:CIBA Vision
Periodat 2004-12-31
 
IDI-2003-CIBA
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:CIBA Vision
Periodat 2003-12-31
 
IDI-2004-AH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Animal Health
Periodat 2004-12-31
 
IDI-2003-AH
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Animal Health
Periodat 2003-12-31
 
IDI-2004-Corp
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Corporate
Periodat 2004-12-31
 
IDI-2003-Corp
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Corporate
Periodat 2003-12-31
 
IDI-2004-Continuing
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2004-12-31
 
IDI-2003-Continuing
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Continuing
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2003-12-31
 
IDI-2004-Agri
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Agribusiness
Periodat 2004-12-31
 
IDI-2003-Agri
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Agribusiness
Periodat 2003-12-31
 
IDI-2004-Discontinued
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2004-12-31
 
IDI-2003-Discontinued
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Discontinued
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2003-12-31
 
IDI-2004-Total
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Total
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2004-12-31
 
IDI-2003-Total
Entity IDSAMP
Schemehttp://www.sampleCompany.com
Segmentcompany:Operations (Placeholder)//operations:Total
Segmentcompany:Sectors (Placeholder)//sectors:Group
Periodat 2003-12-31


Extended Links
ID
RoleDefault Link [http://www.xbrl.org/2003/role/link]
ID
RolePrimaryConcepts [http://www.SampleCompany.com/PrimaryConcepts]
ID
RoleDimensions [http://www.SampleCompany.com/Dimensions]
ID
RoleHypercube [http://www.SampleCompany.com/Hypercube]


Units
IDU-Euros
Measure<measure>iso4217:EUR</measure>
IDU-Pure
Measure<measure>pure</measure>


Performance Statistics
(seconds)
DTS grammars cached0
XML Validation0.100144
Numeric context period checks0
Build calculation tree graph0
Evaluate formula dependency0
Evaluate required and essence-aliased facts0.5908496
Calculation tree roll-ups pass 10.1802592
Independent formula execution 0
Begin dimension rollup validation0
... AccrualBasedCapitalAdditionsForPrimarySegment roll-ups pass 10.2804032
... ProfitLoss roll-ups pass 10.0100144
... ProfitLossAttributableToEquityHoldersOfParent roll-ups pass 10.0200288
... ProfitLossAttributableToMinorityInterest roll-ups pass 10.0200288
... ProfitLossBeforeTax roll-ups pass 10.0200288
... PropertyPlantAndEquipmentNet roll-ups pass 10.1602304
... ResearchAndDevelopment roll-ups pass 10.150216
... RestructuringCosts roll-ups pass 10.1602304
... ResultForPrimarySegment roll-ups pass 10.1602304
... RevenueForPrimarySegmentTotal roll-ups pass 10.150216
... SalesFromTransactionsWithOtherSegmentsForSegment roll-ups pass 10.0701008
... Amortisation roll-ups pass 10.1702448
... AssetsTotal roll-ups pass 10.1602304
... ShareOfProfitLossFromEquityAccountedInvestmentsForPrimarySegment roll-ups pass 10.150216
... Depreciation roll-ups pass 10.1802592
... EquityAndLiabilitiesTotal roll-ups pass 10.150216
... EquityMethodAccountedInvestmentsTotal roll-ups pass 10.1602304
... EquityTotal roll-ups pass 10.1602304
... FinanceCostsForNonFinancialActivities roll-ups pass 10.0200288
... ImpairmentLossRecognisedDirectlyIntoEquityForPrimarySegment roll-ups pass 10.150216
... IncomeTaxExpenseIncome roll-ups pass 10.0200288
... LiabilitiesTotal roll-ups pass 10.150216
... SalesToExternalCustomersForSegment roll-ups pass 10.1301872
... NumberOfEmployeesAtEndOfPeriod roll-ups pass 10.1602304
Update displayed instance0
Finish0

Product version: 6.403.2221.19361 (2006-01-30 11:45)

Software and look and feel © 2002-2006
Universal Business Matrix, inc (UBmatrix)
803 Kirkland Avenue, Suite 200
Kirkland, Washington, USA 98033-6318